A detailed history of Isthmus Partners, LLC transactions in Iradimed Corp stock. As of the latest transaction made, Isthmus Partners, LLC holds 71,905 shares of IRMD stock, worth $3.16 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
71,905
Previous 7,331 880.83%
Holding current value
$3.16 Million
Previous $348,000 808.91%
% of portfolio
0.37%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$41.17 - $47.29 $2.66 Million - $3.05 Million
64,574 Added 880.83%
71,905 $3.16 Million
Q4 2023

Feb 12, 2024

BUY
$37.31 - $47.47 $273,519 - $348,002
7,331 New
7,331 $348,000
Q2 2023

Aug 03, 2023

SELL
$38.88 - $50.61 $1,205 - $1,568
-31 Reduced 0.31%
9,937 $474,000
Q1 2023

May 10, 2023

BUY
$28.48 - $42.14 $283,888 - $420,051
9,968 New
9,968 $392,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $552M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.